| Prediction and validation of protein intermediate states from structurally rich ensembles and coarse-grained simulations L Orellana, O Yoluk, O Carrillo, M Orozco, E Lindahl Nature communications 7 (1), 12575, 2016 | 77 | 2016 |
| FFParam: Standalone package for CHARMM additive and Drude polarizable force field parametrization of small molecules A Kumar, O Yoluk, AD MacKerell Jr Journal of Computational Chemistry 41 (9), 958-970, 2020 | 75 | 2020 |
| Assessment of homology templates and an anesthetic binding site within the γ-aminobutyric acid receptor EJ Bertaccini, O Yoluk, ER Lindahl, JR Trudell Anesthesiology 119 (5), 1087-1095, 2013 | 38 | 2013 |
| Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine M Nys, E Wijckmans, A Farinha, Ö Yoluk, M Andersson, M Brams, ... Proceedings of the National Academy of Sciences 113 (43), E6696-E6703, 2016 | 36 | 2016 |
| Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin Ö Yoluk, T Brömstrup, EJ Bertaccini, JR Trudell, E Lindahl Biophysical journal 105 (3), 640-647, 2013 | 35 | 2013 |
| Conformational gating dynamics in the GluCl anion-selective chloride channel O Yoluk, E Lindahl, M Andersson ACS chemical neuroscience 6 (8), 1459-1467, 2015 | 21 | 2015 |
| eBDIMS server: protein transition pathways with ensemble analysis in 2D-motion spaces L Orellana, J Gustavsson, C Bergh, O Yoluk, E Lindahl Bioinformatics 35 (18), 3505-3507, 2019 | 15 | 2019 |
| Functional characterization of neurotransmitter activation and modulation in a nematode model ligand‐gated ion channel SA Heusser, Ö Yoluk, G Klement, EA Riederer, E Lindahl, RJ Howard Journal of neurochemistry 138 (2), 243-253, 2016 | 6 | 2016 |
| Exploring the Conformational Impact of Glycine Receptor TM1-2 Mutations Through Coarse-Grained Analysis and Atomistic Simulations AR Mhashal, O Yoluk, L Orellana Frontiers in Molecular Biosciences, 542, 2022 | 3 | 2022 |
| Simple Synthesis of a Heterocyclophane Exhibiting Anti‐c‐Met Activity by Acting as a Hatch Blocking Access to the Active Site T Takimoto, H Sasaki, H Tsue, H Takahashi, AD MacKerell, K Nakano, ... Chemistry–A European Journal, 2020 | 1 | 2020 |
| Targeting sortilin RA Broom, GL Butterfoss, CE Ing, TY Lu, FE Lui, S Popa, TA Stone, ... US Patent App. 18/531,211, 2024 | | 2024 |
| Abstract PO5-27-05: Computational design and validation of a novel peptide-drug conjugate for treatment of triple negative breast cancer F Liu, A Zhai, O Yoluk, A Broom, T Stone, G Butterfoss, S Popa, T Li, ... Cancer Research 84 (9_Supplement), PO5-27-05-PO5-27-05, 2024 | | 2024 |
| In vivo efficacy of a novel peptide-conjugated drug in patient-derived xenograft models of breast cancer MJ Elliott, M Mcguire, J Silvester, C Tobin, SE Ghamrasni, F Lui, A Zhai, ... Cancer Research 84 (6_Supplement), 5911-5911, 2024 | | 2024 |
| Elucidating the Gating Mechanism of Cys-Loop Receptors Ö Yoluk KTH Royal Institute of Technology, 2016 | | 2016 |
